The Prognostic Value of HLA DR4 and B27 Antigens in Early Rheumatoid Arthritis

References

• Stastny P. Mixed lymphocyte culture typing cells from patients with rheumatoid arthritis. Tissue Antigens 1974; 4: 571–9
   Google Scholar
• Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869–71
   PubMed Web of Science ®Google Scholar
• Tiwari J L, Terasaki P I. HLA and disease associations. Springer, New York 1985
   Google Scholar
• Schiff B, Mizrachi Y, Ordag S, Gazit E. Association of HLA-Aw3l and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis 1982; 41: 403–4
   PubMed Web of Science ®Google Scholar
• Jaraquernada D, Ollier W, Awad J, et al. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986; 45: 627–36
   PubMedGoogle Scholar
• Westedt M L, Breedveld F C, Schreuder G MTH, D'Amaro J, Cats A, de Vries R RP. Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis 1986; 45: 534–8
   PubMedGoogle Scholar
• Calin A, Elswood J, Klouda P T. Destructive arthritis, rheumatoid factor, and HLA-DR4: susceptibility versus severity, a case-control study. Arthritis Rheum 1989; 32: 1221–5
   PubMedGoogle Scholar
• van Zeben D, Hazes J MW, Zwinderman A H, et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum 1991; 34: 822–30
   PubMed Web of Science ®Google Scholar
• Sillman A J, Reeback J, Jaraquemada D. HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritis. Rheumatol Int 1986; 6: 233–5
   PubMedGoogle Scholar
• Stockman A, Emery P, Doyle T, Hopper J, Tait B, Muirden K. Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA-DR antigens in rheumatoid arthritis. J Rheumatol 1991; 18: 1001–7
   PubMedGoogle Scholar
• Brewerton D A, Caffrey M, Hart F D, James D CO, Nicholls A, Sturrock R D. Ankylosing spondylitis and HLA-A27. Lancet 1973; i: 904–7
   Google Scholar
• Schlosstein L, Terasaki P I, Bluestone R, Pearson C M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704–6
   PubMed Web of Science ®Google Scholar
• Lies R B, Messner R P, Troup G M. Histocompatability antigens and rheumatoid arthritis. Arthritis Rheum 1972; 15: 524–9
   PubMed Web of Science ®Google Scholar
• Dequeker J, Decock T, Walravens M, van de Putte I. A systematic survey of the HLA-B27 prevalence in inflammatory rheumatic diseases. J Rheumatol 1978; 5: 452–9
   PubMed Web of Science ®Google Scholar
• Panayi G S, Wooley P, Batchelor J R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J 1978; 2: 1326–8
   PubMed Web of Science ®Google Scholar
• Bjelle A, Cedergren B, RantapääDahlquist S. HLA B27 in the population of northern Sweden. Scand J Rheumatol 1982; 11: 23–6
   PubMed Web of Science ®Google Scholar
• Isomäki H, Koota K, Martio J, Nissilä M, Tiilikainen A. HLA-A27 and arthritis. Ann Clin Res 1975; 7: 138–45
   PubMedGoogle Scholar
• Hakala M, van Assendelft A HW, Ilonen J, Jalava S, Tiilikainen A. Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis 1986; 45: 177–82
   PubMed Web of Science ®Google Scholar
• Khan M A, Wolfe F, Kleinheksel M, Molta C. HLA DR and B27 antigens in familial and sporadic rheumatoid arthritis. Scand J Rheumatol 1987; 16: 433–6
   PubMed Web of Science ®Google Scholar
• van der Linden J MJP, de Ceulaer K, van Romunde L KJ, Cats A. Ankylosing spondylitis without HLA B27. J Rheumatol 1977; 4(suppl 3)54–6
   Google Scholar
• Woodrow J C, Eastmond C J. HLA B27 and the genetics of ankylosing spondylitis. Ann Rheum Dis 1978; 37: 504–9
   PubMedGoogle Scholar
• Linssen A, Feltkamp T EW. B27 positive diseases versus B27 negative diseases. Ann Rheum Dis 1988; 47: 431–9
   PubMedGoogle Scholar
• Fallahi S, Halla J T, Hardin J G, Jr. The influence of B27 antigen on the clinical and radiographic picture of definite or classical rheumatoid arthritis. J Rheumatol 1982; 9: 13–7
   PubMed Web of Science ®Google Scholar
• Chales G, Coutard J, Pawlotsky Y, et al. Arthrites B27 -DR4 et recherche d'une influence symptomatique des antigenes B27 dans la polyarthrite rhumatoide et DR4 dans la spondylarthrite ankylosante. Rev Rhum 1983; 50: 778–81
   Google Scholar
• RantapääDahlqvist S, Nordmark L G, Bjelle A. HLA-B27 and involvement of sacroiliac joints in rheumatoid arthritis. J Rheumatol 1984; 11: 27–32
   PubMedGoogle Scholar
• Young A, Corbett M, Jaraquemada D, Festenstein H, Roitt I. HLA antigen associations with radiological changes in the hands, feet, and cervical spine in early rheumatoid arthritis. Dis Markers 1986; 4: 133–7
   PubMedGoogle Scholar
• Ropes M, Bennett G A, Cobb S, Jacox R, Jessar R A. 19.58 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Ritchie D M, Boyle J A, McInnes J M, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 393406
   Google Scholar
• Amos D, Badir H, Boyle W, Mc Queen M, Tiilikainen A. A simple microcytotoxicity test. Transplantation 1969; 7: 220–3
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977; 18: 481–91
   PubMed Web of Science ®Google Scholar
• Bardin T, Legrand L, Naveau B, et al. HLA antigens and seronegative rheumatoid arthritis. Ann Rheum Dis 1985; 44: 50–3
   PubMedGoogle Scholar
• Walton K, Dyer P, Grennan D, Haeney M, Harris R. Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis. J Rheumatol 1985; 12: 223–6
   PubMedGoogle Scholar
• Stastny P, Ball E J, Khan M A, Olsen N J, Pincus T, Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol 1988; 27(suppl II)132–8
   PubMedGoogle Scholar
• Feigenbaum S L, Masi A T, Kaplan S B. Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. Am J Med 1979; 66: 377–84
   PubMed Web of Science ®Google Scholar
• Sherrer Y S, Bloch D A, Mitchell D M, Young D Y, Fries J F. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986; 29: 494–500
   PubMed Web of Science ®Google Scholar
• Young A, Jaraquemada D, Awad J, et al. Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities. Arthritis Rheum 1984; 27: 20–5
   PubMed Web of Science ®Google Scholar
• Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A. HLA-antigen 27 and reactive arthritis. Lancet 1973; ii: 157
   Google Scholar
• Pasternack A, Tiilikainen A. HLA-B27 in rheumatoid arthritis and amyloidosis. Tissue Antigens 1977; 9: 80–9
   PubMedGoogle Scholar
• Woodrow J C. Histocompatibility antigens and rheumatic diseases. Semin Arthritis Rheum 1977; 6(252)33–5
   Google Scholar
• RantapääDahlqvist S. Genetic markers in rheumatoid arthritis. Scand J Rheumatol 1986, suppl 58: 1–29
   PubMedGoogle Scholar
• Dilsen N, Mc Ewen C, Poppel M, Gersh W J, Di Tata D, Carmel P. A comparative roentgenologic study of rheumatoid arthritis and rheumatoid (ankylosing) spondylitis. Arthritis Rheum 1962; 5: 341–68
   PubMed Web of Science ®Google Scholar
• Jurik A G, de Carvalho A, Graudal H. Radiographic visualisation of seropositive rheumatoid arthritis in carriers of HLA-B27. Fortschr Rontgenstr 1987; 147: 14–20
   Google Scholar
• Winfield J, Cooke D, Brook A S, Corbett M. A prospective study of the radiological changes in the cervical spine in early rheumatoid disease. Ann Rheum Dis 1981; 40: 109–14
   PubMedGoogle Scholar